Guangzhou Wondfo Biotech Co.,Ltd Financials

Market Capitalization CN¥11.49 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	21.12
Forward PE	13.71
Price to Sales TTM	CN¥3.90
Price to Book MRQ	CN¥2.09
Enterprise to Revenue	3.40
Enterprise to EBITDA	14.50

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	17.80%
Operating Margin	15.05%
Return on Assets TTM	5.07%
Return on Equity TTM	10.27%

Income Statement

Revenue TTM	CN¥2,941,852,928
Revenue per Share TTM	CN¥6.37
Quarterly Revenue Growth	17.50%
Gross Profit TTM	CN¥1,731,143,245
EBITDA	CN¥615,098,579
Net Income to Common TTM	CN¥523,749,344
Diluted EPS TTM	CN¥1.13
Quarterly Earnings Growth YoY	22.70%

Balance Sheet

Total Cash MRQ	CN¥2,114,914,688
Total Cash per Share MRQ	CN¥4.42
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	10.55
Current Ratio MRQ	7.44
Book Value per Share MRQ	CN¥11.42

Cash Flow

Operating Cash Flow TTM	CN¥538,266,240
Levered Free Cash Flow TTM	CN¥-237,318,768

300482 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	481,424,000
Float Shares	271,867,009
Avg 10 Volume	5,829,242
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	45.10%
% Held by Institutions	10.53%

Stock Price Summary

Beta	0.69
Fifty Two Week Low	CN¥19.20
Fifty Two Week High	CN¥31.50
Fifty Two Week Change	-17.36%
Day 50 MA	CN¥25.02
Day 200 MA	CN¥25.03

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.60
Forward Annual Dividend Yield	7.23%
Trailing Annual Dividend Rate	CN¥0.40
Trailing Annual Dividend Yield	1.81%
Payout Ratio	35.40%
Dividend Date
Ex Dividend Date	2024-06-05
Last Split Factor
Last Split Date	2021-05-26